中国科学院机构知识库网格
Chinese Academy of Sciences Institutional Repositories Grid
Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches

文献类型:期刊论文

作者Xia, Jiaxuan3,4; Ma, Shaojie5,6; Zhu, Xi2,7; Chen, Chen3,4; Zhang, Ru3,4; Cao, Zhonglian3,4; Chen, Xing3,4; Zhang, Longlong3,4; Zhu, Ying3,4; Zhang, Shuya3,4
刊名SCIENCE ADVANCES
出版日期2022-02-01
卷号8期号:6页码:19
ISSN号2375-2548
DOI10.1126/sciadv.abj1262
通讯作者Wang, Jianxin(jxwang@fudan.edu.cn)
英文摘要Limited circulating tumor cells (CTCs) capturing efficiency and lack of regulation capability on CTC-supportive metastatic niches (MNs) are two main obstacles hampering the clinical translation of conventional liposomes for the treatment of metastatic breast cancers. Traditional delivery strategies, such as ligand modification and immune modulator co-encapsulation for nanocarriers, are inefficient and laborious. Here, a multifunctional Rg3 liposome loading with docetaxel (Rg3-Lp/DTX) was developed, in which Rg3 was proved to intersperse in the phospholipid bilayer and exposed its glycosyl on the liposome surface. Therefore, it exhibited much higher CTC- capturing efficiency via interaction with glucose transporter 1 (Glut1) overexpressed on CTCs. After reaching the lungs with CTCs, Rg3 inhibited the formation of MNs by reversing the immunosuppressive microenvironment. Together, Rg3-Lp/DTX exhibited excellent metastasis inhibition capacity by CTC ("seeds") neutralization and MN ("soil") inhibition. The strategy has great clinical translation prospects for antimetastasis treatment with enhanced therapeutic efficacy and simple preparation process.
WOS关键词NF-KAPPA-B ; RESISTANT ; COMBINATION ; PACLITAXEL ; STRATEGIES ; THERAPY
资助项目National Natural Science Foundation of China[82074277] ; National Natural Science Foundation of China[8177391] ; National Natural Science Foundation of China[81690263] ; Development Project of Shanghai Peak Disciplines-Integrated Medicine[20180101] ; National Key R&D Program of China[2020YFC0841400] ; Strategic Priority Research Program of the Chinese Academy of Sciences[XDPB2505]
WOS研究方向Science & Technology - Other Topics
语种英语
WOS记录号WOS:000757383500003
出版者AMER ASSOC ADVANCEMENT SCIENCE
源URL[http://119.78.100.183/handle/2S10ELR8/300333]  
专题新药研究国家重点实验室
通讯作者Wang, Jianxin
作者单位1.Fudan Univ, Inst Integrat Med, Shanghai 201203, Peoples R China
2.Shanghai Jiao Tong Univ, Sch Biomed Engn, Shanghai 200030, Peoples R China
3.Fudan Univ, Sch Pharm, Dept Pharmaceut, Shanghai 201203, Peoples R China
4.Minist Educ, Key Lab Smart Drug Delivery, Shanghai 201203, Peoples R China
5.Chinese Acad Sci, Drug Discovery & Design Ctr, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
6.Huazhong Univ Sci & Technol, Coll Life Sci & Technol, Key Lab Mol Biophys, Minist Educ, Wuhan 430071, Peoples R China
7.Shanghai Jiao Tong Univ, Med X Res Inst, Shanghai Canc Inst, State Key Lab Oncogenes & Related Genes, Shanghai 200030, Peoples R China
推荐引用方式
GB/T 7714
Xia, Jiaxuan,Ma, Shaojie,Zhu, Xi,et al. Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches[J]. SCIENCE ADVANCES,2022,8(6):19.
APA Xia, Jiaxuan.,Ma, Shaojie.,Zhu, Xi.,Chen, Chen.,Zhang, Ru.,...&Wang, Jianxin.(2022).Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches.SCIENCE ADVANCES,8(6),19.
MLA Xia, Jiaxuan,et al."Versatile ginsenoside Rg3 liposomes inhibit tumor metastasis by capturing circulating tumor cells and destroying metastatic niches".SCIENCE ADVANCES 8.6(2022):19.

入库方式: OAI收割

来源:上海药物研究所

浏览0
下载0
收藏0
其他版本

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。